The rise in vancomycin-resistant enterococcus faecium in germany: Data from the german antimicrobial resistance surveillance (ars)

Antimicrobial Resistance and Infection Control

Volumn 8, Issue 1, 2019, Pages

  Markwart, Robby ^a   Willrich, Niklas ^a   Haller, Sebastian ^a   Noll, Ines ^a   Koppe, Uwe ^a   Werner, Guido ^a   Eckmanns, Tim ^a   Reuss, Annicka ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

Author keywords

Antimicrobial resistance; ARS; Enterococcus faecium; Epidemiology; Surveillance; Vancomycin resistance

Indexed keywords

VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIUM ISOLATE; CHILD; DISEASE ASSOCIATION; DRUG SENSITIVITY; ENTEROCOCCUS FAECIUM; FEMALE; GERMANY; GROUPS BY AGE; HEALTH CARE SYSTEM; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; NEWBORN; NONHUMAN; PATIENT CARE; PRIORITY JOURNAL; SECONDARY CARE CENTER; TREND STUDY; VANCOMYCIN RESISTANT ENTEROCOCCUS; AGEISM; CLASSIFICATION; GRAM POSITIVE INFECTION; HEALTH SURVEY; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PRESCHOOL CHILD; REGRESSION ANALYSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGEISM; CHILD; CHILD, PRESCHOOL; ENTEROCOCCUS FAECIUM; FEMALE; GERMANY; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; POPULATION SURVEILLANCE; REGRESSION ANALYSIS; VANCOMYCIN-RESISTANT ENTEROCOCCI; YOUNG ADULT;

EID: 85071773358     PISSN: None     EISSN: 20472994     Source Type: Journal    
DOI: 10.1186/s13756-019-0594-3     Document Type: Article

References (50)

1. Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology. 2009;155(Pt 6):1749-57.
2. Arias CA, Murray BE. The rise of the Enterococcus: beyond vancomycin resistance. Nat Rev Microbiol. 2012;10(4):266-78.
3. Weiner LM, et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol. 2016;37(11):1288-301.
4. Behnke M, et al. Nosocomial infection and antibiotic use: a second national prevalence study in Germany. Dtsch Arztebl Int. 2013;110(38):627-33.
5. Lee T, et al. Antimicrobial-resistant CC17 Enterococcus faecium: the past, the present and the future. J Glob Antimicrob Resist. 2019;16:36-47.
6. Lebreton F, et al. Emergence of epidemic multidrug-resistant Enterococcus faecium from animal and commensal strains. MBio. 2013;4(4).
7. Liese J, et al. Expansion of Vancomycin-Resistant Enterococcus faecium in an Academic Tertiary Hospital in Southwest Germany: a Large-Scale Whole-Genome-Based Outbreak Investigation. Antimicrob Agents Chemother. 2019;63(5).
8. O'Driscoll T, Crank CW. Vancomycin-resistant enterococcal infections: epidemiology, clinical manifestations, and optimal management. Infect Drug Resist. 2015;8:217-30.
9. Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence. 2012;3(5):421-33.
10. Werner G, et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 2008;13(47).
11. Tacconelli E, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318-27.
12. Control, E.C.f.D.P.a., Surveillance of antimicrobial resistance in Europe - Annual report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2017, in Stockholm: ECDC. 2018.
13. Remschmidt C, et al. Continuous increase of vancomycin resistance in enterococci causing nosocomial infections in Germany - 10 years of surveillance. Antimicrob Resist Infect Control. 2018;7:54.
14. Noll I, et al. Antimicrobial resistance in Germany. Four years of antimicrobial resistance surveillance (ARS). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2012;55(11-12):1370-6.
15. Schweickert B, et al. MRSA-surveillance in Germany: data from the antibiotic resistance surveillance system (ARS) and the mandatory surveillance of MRSA in blood. Eur J Clin Microbiol Infect Dis. 2012;31(8):1855-65.
16. Koppe U, et al. Carbapenem non-susceptibility of Klebsiella pneumoniae isolates in hospitals from 2011 to 2016, data from the German antimicrobial resistance surveillance (ARS). Antimicrob Resist Infect Control. 2018;7:71.
17. Huang SS, et al. Improving the assessment of vancomycin-resistant enterococci by routine screening. J Infect Dis. 2007;195(3):339-46.
18. Team, R.C., R: A language and environment for statistical computing. R Foundation for Statistical Computing. Available online at https://www.R-project.org/. 2018.
19. Rao, J.N.K. and A. Scott, On Chi-squared Tests For Multiway Contigency Tables with Proportions Estimated From Survey Data. Vol. 12. 1984.
20. Datenlieferung gem. § 21 KHEntgG. 2019 [cited 2019 March 15th 2019]; Available from: https://www.g-drg.de/Datenlieferung_gem._21_KHEntgG.
21. Prematunge C, et al. VRE and VSE bacteremia outcomes in the era of effective VRE therapy: a systematic review and meta-analysis. Infect Control Hosp Epidemiol. 2016;37(1):26-35.
22. Linden PK, et al. Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E. faecium. Clin Infect Dis. 1996;22(4):663-70.
23. Garbutt JM, et al. Association between resistance to vancomycin and death in cases of Enterococcus faecium bacteremia. Clin Infect Dis. 2000;30(3):466-72.
24. Cassini A, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European economic area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56-66.
25. Behnke M, et al. The prevalence of nosocomial infection and antibiotic use in German hospitals. Dtsch Arztebl Int. 2017;114(50):851-7.
26. Infektionsprävention, K.f.K.u., Hygienemaßnahmen zur Prävention der Infektion durch Enterokokken mit speziellen Antibiotikaresistenzen. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz, 2018. 61(10): p. 1310-1361.
27. Buetti N, et al. Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey. Antimicrobial Resistance & Infection Control. 2019;8(1):16.
28. Leong KWC, et al. Emergence of vancomycin-resistant Enterococcus faecium at an Australian hospital: a whole genome sequencing analysis. Sci Rep. 2018;8(1):6274.
29. Canada, P.H.A.o., Canadian Antimicrobial Resistance - 2017 Report, in CANADIAN ANTIMICROBIAL RESISTANCE SURVEILLANCE SYSTEM. 2018, Public Health Agency of Canada Ottawa, ON K1A 0K9.
30. Canada, P.H.A.o., Canadian Antimicrobial Resistance Surveillance System - Update 2018, in Canadian Antimicrobial Resistance Surveillance System. 2018, Public Health Agency of Canada: Ottawa, Canada.
31. Batzing-Feigenbaum J, et al. Outpatient Antibiotic Prescription. Dtsch Arztebl Int. 2016;113(26):454-9.
32. Forstner C, et al. Non-linear significant relationship between use of glycopeptides and isolation of vancomycin-resistant Enterococcus species in a university hospital setting. Antimicrob Resist Infect Control. 2015;4:25.
33. Dyar OJ, et al. How can we improve antibiotic prescribing in primary care? Expert Rev Anti-Infect Ther. 2016;14(4):403-13.
34. Klauber J, et al. Stuttgart, Germany. Krankenhaus-Report. 2015:2015.
35. Moemen D, Tawfeek D, Badawy W. Healthcare-associated vancomycin resistant Enterococcus faecium infections in the Mansoura University hospitals intensive care units, Egypt. Braz J Microbiol. 2015;46(3):777-83.
36. Sabouni F, et al. High frequency of vancomycin resistant Enterococcus faecalis in children: an alarming concern. J Prev Med Hyg. 2016;57(4):E201-e204.
37. Tripathi A, et al. Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a tertiary Care Hospital in Northern India. Indian J Med Microbiol. 2016;34(1):38-45.
38. Lucas GM, et al. Vancomycin-resistant and vancomycin-susceptible enterococcal bacteremia: comparison of clinical features and outcomes. Clin Infect Dis. 1998;26(5):1127-33.
39. Monteserin N, Larson E. Temporal trends and risk factors for healthcare-associated vancomycin-resistant enterococci in adults. J Hosp Infect. 2016;94(3):236-41.
40. Adam HJ, et al. Comparison of pathogens and their antimicrobial resistance patterns in paediatric, adult and elderly patients in Canadian hospitals. J Antimicrob Chemother. 2013;68(Suppl 1):i31-7.
41. Ji Z, et al. The Association of age and Antibiotic Resistance of helicobacter pylori: a study in Jiaxing City, Zhejiang Province, China. Medicine (Baltimore). 2016;95(8):e2831.
42. Garcia A, Delorme T, Nasr P. Patient age as a factor of antibiotic resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol. 2017;66(12):1782-9.
43. Karki S, et al. Prevalence and risk factors for VRE colonisation in a tertiary hospital in Melbourne, Australia: a cross sectional study. Antimicrob Resist Infect Control. 2012;1(1):31.
44. Laudisio A, et al. The burden of comorbidity is associated with antibiotic resistance among institutionalized elderly with urinary infection: a retrospective cohort study in a single Italian nursing home between 2009 and 2014. Microb Drug Resist. 2017;23(4):500-6.
45. Koch AM, et al. Mortality related to hospital-associated infections in a tertiary hospital; repeated cross-sectional studies between 2004-2011. Antimicrob Resist Infect Control. 2015;4:57.
46. Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501-9.
47. Klevens RM, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122(2):160-6.
48. Alon D, et al. Predictors and outcomes of infection-related hospital admissions of heart failure patients. PLoS One. 2013;8(8):e72476.
49. Kramer TS, et al. The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections. Antimicrob Resist Infect Control. 2018;7:133.
50. Noll I, et al. Antibiotic consumption and antimicrobial resistance in human and veterinary medicine: an overview of established national surveillance systems in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018;61(5):522-32.